Dallas College has been awarded a U.S. Economic Development Administration grant to help underserved communities…
A trial to look at the use of a drug targeting refractory metastatic colorectal cancer…
Epigenic Therapeutics Co., Ltd., a Chinese biotech gene editing company, has secured $20 million in…
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
Three entities have joined forces to develop allogenic immune cell therapies based on a platform…
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…
This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at…
Patients with moderate to severe ulcerative colitis (UC) can now be enrolled onto two phase…
Immunis Inc., a private U.S. biotech company developing a novel treatment for age and disease-related…
An enzyme that efficiently degrades and metabolizes cocaine has been given a ‘cooperative agreement grant’…
Sanofi and Innovent Biologics are to collaborate on providing medicines to patients in China with…
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
